Phase II Study of AB-106 to Treat Patients With Solid Tumors With NTRK Gene Fusion
Clinical trial NCT04617054 · TERMINATED
Trial details
- NCT number
- NCT04617054
- Sponsor
- Nuvation Bio Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2024-12-06
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.